首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

【2h】

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

机译：前列腺癌和盆腔淋巴结的2期随机试验与仅局部放疗的晚期局部前列腺癌（PIVOTAL）的毒性和患者报告的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo establish the toxicity profile of high-dose pelvic lymph node intensity-modulated radiation therapy (IMRT) and to assess whether it is safely deliverable at multiple centers.

机译：目的建立高剂量盆腔淋巴结强度调节放射治疗（IMRT）的毒性特征，并评估其在多个中心是否安全。

著录项

期刊名称 Elsevier Sponsored Documents
作者
David Dearnaley; Clare L. Griffin; Rebecca Lewis; Philip Mayles; Helen Mayles; Olivia F. Naismith; Victoria Harris; Christopher D. Scrase; John Staffurth; Isabel Syndikus; Anjali Zarkar; Daniel R. Ford; Yvonne L. Rimmer; Gail Horan; Vincent Khoo; John Frew; Ramachandran Venkitaraman; Emma Hall;
展开▼
作者单位

展开▼
年(卷),期 -1(103),3
年度 -1
页码 605–617
总页数 13
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL) [J] . Dearnaley David, Griffin Clare L., Lewis Rebecca, International Journal of Radiation Oncology, Biology, Physics . 2019,第3期

机译：毒性和患者报告的前列腺和盆腔淋巴结试验的2阶段随机试验与前列腺癌的前列腺癌（关键）（关键）
2. Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer [J] . Ferreira M. R., Thomas K., Truelove L., Clinical oncology . 2019,第6期

机译：盆腔淋巴结放射治疗前期局部前列腺癌的II期试验中的剂量测定和胃肠道毒性关系
3. Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial [J] . Taneja Samir S. The Journal of Urology . 2016,第5期

机译：回复：中度局部前列腺癌患者的超分割放疗与常规分割放疗：2年期患者报告的随机，非自卑，3期CHHiP试验结果
4. Functional Molecular Imaging of Prostate Cancer Lymph Node Metastases: Adenovirus-Medlated Lymph Node Detection [C] . Saul J. Priceman, Jeremy B. Burton, Lily Wu International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：前列腺癌淋巴结转移的功能分子成像：腺病毒 - 髓质淋巴结检测
5. Alpha-methylacyl-CoA racemase: A candidate gene for prostate cancer and advanced distal colorectal adenomas in the prostate, lung, colorectal, and ovarian cancer screening trial. [D] . Daugherty, Sarah. 2007

机译：α-甲基酰基辅酶A消旋酶：在前列腺癌，肺癌，结肠直肠癌和卵巢癌筛查试验中，前列腺癌和晚期远端结肠直肠腺瘤的候选基因。
6. Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer [O] . M.R. Ferreira, K. Thomas, L. Truelove, -1

机译：在晚期局部前列腺癌盆腔淋巴结放疗的II期试验中剂量测定法和胃肠道毒性关系
7. Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer [O] . M.R. Ferreira, K. Thomas, L. Truelove, 2019

机译：盆腔淋巴结放射治疗前期局部前列腺癌的II期试验中的剂量测定和胃肠道毒性关系

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

摘要

著录项

相似文献

相关主题

期刊订阅